Updated questions and answers on the Windsor Framework – Exempt medicinal products
25/10/2024 Regulatory newsWe updated our webpage relating to the impact of the Windsor Framework on the regulation of human medicines.
The page is based on questions the HPRA has received from companies and includes updated information on exempt medicinal products moving between Northern Ireland and the Republic of Ireland.
Further questions on this topic can be sent to brexit@hpra.ie. We will continue to update the page as necessary.